Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
about
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatGenetic and Structural Characterization of an L201P Global Suppressor Substitution in TEM-1 β-LactamaseCombining computational and experimental screening for rapid optimization of protein propertiesIn vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclorAnalysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamaseNegative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme's Conformational Freedom and Disorder.
P2860
Q24550671-87E5CB6E-F6E1-484B-AE67-91E5B805CEA3Q27652316-BAD7563A-E7FA-4853-8360-B14DB3396100Q34414821-5C39D50F-778F-49FA-9689-6C6CE215A5F4Q38626867-7D9FBFB2-3662-4B75-B966-F93BA5F24C5AQ39652959-4970EB9D-7565-412D-974D-FCBE1E8EA223Q39657859-60114D9E-1D9B-4FD8-8E64-EDC1AF80F35BQ39686774-4C06AD48-F7ED-49FD-8713-493BFF24A0D6Q39792503-C655666A-5A17-470B-A60F-CBB46102404DQ42574291-CA7DEBBE-3487-4577-9A82-140CEC3534DDQ42686900-F8E69A21-601E-48DF-A8C3-36167CA26076
P2860
Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Construction and characterizat ...... to beta-lactamase inhibitors.
@en
Construction and characterizat ...... to beta-lactamase inhibitors.
@nl
type
label
Construction and characterizat ...... to beta-lactamase inhibitors.
@en
Construction and characterizat ...... to beta-lactamase inhibitors.
@nl
prefLabel
Construction and characterizat ...... to beta-lactamase inhibitors.
@en
Construction and characterizat ...... to beta-lactamase inhibitors.
@nl
P2093
P2860
P1476
Construction and characterizat ...... to beta-lactamase inhibitors.
@en
P2093
G L French
K P Shannon
P D Stapleton
P2860
P304
P407
P577
1999-08-01T00:00:00Z